Join to View Full Profile
9500 Euclid AveCleveland, OH 44195
Phone+1 216-444-2200
Dr. Almassi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Nima Almassi is a Urologic Oncologist at Cleveland Clinic. He obtained his medical degree from the Medical College of Wisconsin, completed urology residency training at Cleveland Clinic, and pursued fellowship in urologic oncology at Memorial Sloan Kettering Cancer Center. He specializes in management of bladder, prostate, kidney, and penile cancer. His research interests includes bladder-sparing treatment in very high risk non-muscle invasive bladder cancer with variant histology, predictive biomarkers of treatment response to multimodal treatment of bladder cancer, the impact of body composition and sarcopenia on treatment outcomes in patients with urologic malignancy, and innovations in surgical treatment of urologic cancers.
Education & Training
Cleveland Clinic FoundationResidency, Urology, 2012 - 2018
Medical College of WisconsinClass of 2012
Certifications & Licensure
OH State Medical License 2020 - 2026
NY State Medical License 2017 - 2021
American Board of Urology Urology
Publications & Presentations
PubMed
- Sarcopenia may increase cisplatin toxicity in bladder cancer patients with borderline renal function.Eiftu S Haile, Zaeem Lone, David Shin, Amy S Nowacki, Nicolas Soputro
BJU International. 2025-05-01 - 1 citationsQuantification of micropapillary component on transurethral resection is associated with likelihood of occult lymph node metastasis at radical cystectomy.Andrew M Wood, Tarik Benidir, Rebecca Campbell, Jianbo Li, Zaeem Lone
Urologic Oncology. 2025-04-01 - 1 citationsProlonged ischaemia during partial nephrectomy: impact of warm vs cold.Akira Kazama, Carlos Munoz-Lopez, Kieran Lewis, Worapat Attawettayanon, Nityam Rathi
BJU International. 2025-04-01
Press Mentions
BCG Response in Bladder Cancer Cases Linked to Tumor MicrobiomeMay 16th, 2023- Gopa Iyer, MD, on Glandular-Phenotype Bladder CancerOctober 27th, 2022
- Clinical Challenge: Urinary Diversion Methods in Bladder CancerDecember 6th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
